Regeneron Pharmaceuticals (REGN) Gross Profit (2009 - 2026)
Regeneron Pharmaceuticals (REGN) posted quarterly Gross Profit of $3.9 billion for Q2 2026, up 15.59% year-over-year from $3.4 billion in Q2 2025, and up 21.6% quarter-over-quarter from $3.2 billion in Q1 2026.
Regeneron Pharmaceuticals (REGN) Gross Profit (2009 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Gross Profit history runs 18 years deep, the most recent figure standing at $3.9 billion for Q2 2026.
- In Q2 2026, Gross Profit rose 15.59% year-over-year to $3.9 billion; the TTM figure through Jun 2026 stood at $14.2 billion (up 8.54% YoY), while the FY2025 annual figure was $13.2 billion, up 0.67% from the prior year.
- Gross Profit for Q2 2026 stood at $3.9 billion, up from $3.2 billion in the prior quarter.
- The five-year high for Gross Profit was $3.9 billion in Q2 2026, with the low at -$178.0 million in Q4 2022.
- The 5-year median for Gross Profit is $3.2 billion (2023), against an average of $2.8 billion.
- The sharpest annual moves came in 2022 and 2023: Gross Profit slumped 106.71% in 2022, then soared 1951.88% in 2023.
- Regeneron Pharmaceuticals' Gross Profit stood at -$178.0 million in 2022, then soared by 1884.1% to $3.2 billion in 2023, then rose by 9.03% to $3.5 billion in 2024, then increased by 2.98% to $3.6 billion in 2025, then increased by 10.22% to $3.9 billion in 2026.
- Business Quant data shows REGN's Gross Profit at $3.9 billion in Q2 2026, $3.2 billion in Q1 2026, and $3.6 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Roivant Sciences | 26.16 Bn | 26.85 Bn | 1.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.93 Bn |
| Jun 30, 2026 | 3.93 Bn |
| Mar 31, 2026 | 3.31 Bn |
| Mar 31, 2026 | 3.31 Bn |
| Dec 31, 2025 | 3.75 Bn |
| Dec 31, 2025 | 3.75 Bn |
| Sep 30, 2025 | 3.47 Bn |
| Sep 30, 2025 | 3.47 Bn |
| Jun 30, 2025 | 3.40 Bn |
| Jun 30, 2025 | 3.40 Bn |
| Mar 31, 2025 | 2.83 Bn |
| Mar 31, 2025 | 2.83 Bn |
| Dec 31, 2024 | 3.35 Bn |
| Dec 31, 2024 | 3.35 Bn |
| Sep 30, 2024 | 3.46 Bn |
| Sep 30, 2024 | 3.46 Bn |
| Jun 30, 2024 | 3.32 Bn |
| Jun 30, 2024 | 3.32 Bn |
| Mar 31, 2024 | 2.95 Bn |
| Mar 31, 2024 | 2.95 Bn |